A Blood thinner Administered Once
Selected Abstract
A Blood-thinner Administered Once Daily Prevents DVT Among Hospitalized Patients; Largest Clinical Study of its Kind Shows that Almost Half of the Complications and Deaths Due to in-Hospital DVT Can be Prevented with Once Daily Dalteparin Administration.
BOSTON, Aug. 17 /PRNewswire/ -- Current research supports the use of blood-thinners to help acutely ill, hospitalized patients minimize the risk of death from a pulmonary embolism (PE) and its precursor deep vein thrombosis (DVT). However, physicians and patients often do not address this potential ... August 17, 2004; PR Newswire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Brigham and Women's Hospital; A Blood-thinner Administered Once Daily Prevents DVT Among Hospitalized Patients.
2.
A Blood-thinner Administered Once Daily Prevents DVT Among Hospitalized Patients; Largest Clinical Study of its Kind Shows that Almost Half of the Complications and Deaths Due to in-Hospital DVT Can be Prevented with Once Daily Dalteparin Administration.
|
